Collagen + Greens
Natural health product licensed in Canada
- Other names
- Collagen & Greens, Collagen + Pro Greens Lite, Collagen Greens
- Licence holder
- Base Pro Nutrition Inc.
- NPN or DIN-HM
- 80135286
- Status
- Active licence
- Licence date
- 21 October 2024
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Collagène hydrolysé Potency : 7.28 % L-Alanine | 7 g | Not calculated |
| Collagène hydrolysé Potency : 7.31 % L-Serine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 10.1 % L-Glutamic acid | Not specified | Not calculated |
| Collagène hydrolysé Potency : 2.42 % L-Leucine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 0.116 % L-Threonine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 2.48 % L-Valine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 1.09 % L-Isoleucine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 2.25 % L-Methionine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 1.52 % L-Phenylalanine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 0.723 % L-Histidine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 3.31 % L-Lysine | Not specified | Not calculated |
| Collagène hydrolysé Potency : 23.2 % L-Proline | Not specified | Not calculated |
| Spinacia oleracea Source : Spinacia oleracea - feuille | 75 mg | Not calculated |
| Brassica oleracea var. italica Source : Brassica oleracea var. italica - Sommité (herbe) | 100 mg | Not calculated |
| Petroselinum crispum Source : Petroselinum crispum - herb top | 20 mg | Not calculated |
| Arthrospira platensis Source : Arthrospira platensis - en entier | 1,000 mg | Not calculated |
| Inuline Source : Helianthus tuberosus - tubercule | 1,015 mg | Not calculated |
| Chlorella vulgaris Source : Chlorella vulgaris - cellule brisée | 200 mg | Not calculated |
| Medicago sativa Source : Medicago sativa- Sommité (herbe) | 500 mg | Not calculated |
| Brassica oleracea var. viridis Source : Brassica oleracea var. viridis - feuille | 35 mg | Not calculated |
| Ascophyllum nodosum Source : Ascophyllum nodosum - whole | 200 mg | Not calculated |
| Collagène hydrolysé Potency : 4.87 % L-Aspartic acid | Not specified | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps manage/in the management of joint pain. Helps reduce joint pain associated with osteoarthritis. Helps reduce osteoarthritis related joint pain. Source of (the essential amino acid) lysine to help in collagen formation/synthesis. Source of (the) essential amino acid(s) (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, valine) for the maintenance of good health/involved in (muscle) protein synthesis. Source of (the) non-essential amino acid(s) (alanine, arginine, aspartic acid, glutamic acid, glycine, proline, serine, tyrosine) involved in (muscle) protein synthesis. Source of/Provides (an) antioxidant(s) for the maintenance of good health. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80135286
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.